Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital. The funding comes from new investors and existing shareholders in EMEA, US and Asia, and adds to the £29M of new capital raised in Q4 2019. Further information on Oxford Nanopore’s fundraising will be made available after full closing. Oxford Nanopore’s sequencing devices are used […]
Vulcan Capital-led investment will enable Nautilus to bring a next-generation, single-molecule proteomics platform to market. San Carlos, CA and Seattle, WA, May 21, 2020 — Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that […]
SAN DIEGO– Illumina, Inc. (NASDAQ: ILMN) is committed to supporting the global, national and local relief efforts of our customers, employees and communities, as we unite to combat COVID-19. Giving back is in our DNA, and together with the Illumina Corporate Foundation, we have committed more than $10M to support the communities where we live […]
Mérieux Equity Partners and Korys announce the launch of a new investment platform in Venture Capital to support innovative companies in the healthcare and nutrition sectors, in Europe and North America. OMX Europe Venture Fund FPCI (“OMX Europe”) was launched with a significant financial commitment representing more than two thirds of the target size of […]
Vienna, Austria – Lexogen GmbH, a Vienna based Next-Generation Sequencing (NGS) and transcriptomics company, receives funding from the Austria Research Promotion Agency (FFG) for the development of a novel SARS-CoV-2 test method for mass screening. The company has already developed and commercialized multiple methods for high throughput RNA analysis and will base the test on its QuantSeq-Flex Targeted […]
Warburg Pincus brings strong healthcare experience and a global network to support innovation and scale-up as Polyplus serves the gene and cell therapy market. Illkirch, FRANCE –– Polyplus-transfection® SA (“Polyplus”), a developer of innovative and cost-effective technology used in gene and cell therapy, closed on a major investment from Warburg Pincus, a leading global private equity firm […]
LAUDA intensifies involvement with innovative start-up watttron Lauda-Königshofen – The LAUDA DR. R. WOBSER GmbH & Co. KG, the world market leader for precise temperature control, has renewed its support for the Saxon technology start-up watttron. Together with other renowned investors, LAUDA is providing fresh capital of EUR 3.4 million in addition to expertise. LAUDA […]
Researchers from Signature Science, Rice University, University of Maryland, and Fraunhofer USA Center for Experimental Software Engineering will transition the computational tools developed to predict the function and threat potential of short DNA sequences to the end user community. AUSTIN, TEXAS – Signature Science, LLC has been selected to continue their support of the Intelligence […]
PHILADELPHIA – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular $1 million to enable the application of Integral Molecular’s technology platforms to aid in the discovery of vaccines and therapeutics to combat COVID-19. Integral Molecular’s Shotgun Mutagenesis Epitope Mapping platform precisely identifies where antibodies bind to their target proteins, and will be […]
London, UK / MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels. The Company will develop its novel cell bioprocessing technology, utilising microfluidics to tackle the challenges associated with bioprocessing for cell […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
